Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,315 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Low-dose ruxolitinib shows effective in treating myelofibrosis.
Yang Y, Luo H, Zheng Y, Zou Z, Niu T, Jia Y, Zhu H, Liu T, Wu Y, Chang H, Ji J, Li J, Pan L. Yang Y, et al. Among authors: zou z. Ann Hematol. 2021 Jan;100(1):135-141. doi: 10.1007/s00277-020-04311-z. Epub 2020 Oct 20. Ann Hematol. 2021. PMID: 33083863
[Full-cycle Health Management of Multiple Myeloma].
Duan JY, Cui J, Tang WJ, Zou ZQ, Zhang L. Duan JY, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2022 Aug;44(4):673-677. doi: 10.3881/j.issn.1000-503X.13467. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2022. PMID: 36065701 Free article. Review. Chinese.
Single-arm study of camrelizumab plus apatinib for patients with advanced mucosal melanoma.
Zhao L, Ren Y, Zhang G, Zheng K, Wang J, Sha H, Zhao M, Huang R, Kang D, Su X, Wu Y, Zhang W, Lai R, Li L, Mei R, Wang Y, Tian Y, Wang F, Liu B, Zou Z. Zhao L, et al. Among authors: zou z. J Immunother Cancer. 2024 Jun 21;12(6):e008611. doi: 10.1136/jitc-2023-008611. J Immunother Cancer. 2024. PMID: 38908858 Free article. Clinical Trial.
4,315 results